Beta lipid-lowering drugs are also known as beta-lipid-lowering drugs, and their commonly used drugs include gefibrate, fenofibrate, benzapentamide, etc. 1. Gefibrate: It is fast and stable in lowering plasma triglyceride and very low-density lipoprotein, and has the best efficacy in hyperlipidemia with markedly increased plasma triglyceride and accompanied by lowered high-density lipoprotein or elevated low-density lipoprotein. The main adverse reactions are gastrointestinal reactions. The second is dizziness, fatigue, insomnia and so on. Its liver and gallbladder disease, pregnant women prohibit this drug. 2. Fenofibrate: It can reduce the plasma level of blood uric acid and fibrinogen, and reduce plasma viscosity, thus improving hemodynamics. The main adverse reactions are gastrointestinal reactions. The secondary ones are impotence, fatigue, and insomnia. Its renal insufficiency should be used with caution, its liver and gallbladder disease, pregnant women prohibit this drug. 3. Benzafibrate: Its effect is similar to that of gefibrate, and it can reduce FFA, fibrinogen, glycated hemoglobin in plasma, and inhibit the effect of platelet aggregation. The main adverse reactions are gastrointestinal reactions. Followed by dizziness, fatigue, insomnia and so on. This drug is contraindicated in its liver and gallbladder diseases, pregnant women. Renal insufficiency should use this drug with caution. The drug should be used under the guidance of a physician, and if patients with coronary heart disease are taking the drug at the same time, they should remember to review it on time.